The anti-inflammatory effects of sympathectomy in murine antigen-induced arthritis are associated with a reduction of Th1 and Th17 responses

Background Both facilitatory and inhibitory effects of the sympathetic nervous system (SNS) on experimental arthritis have been reported. It is unknown whether such bidirectional effects are inherent to all experimental arthritis models and/or whether critical time windows exist for influences of the SNS on inflammation. Objectives To assess the effect of sympathectomy at different time points on the course and severity of murine antigen-induced arthritis (AIA). Methods AIA was induced in mice. Chemical sympathectomy with 6-hydroxydopamine was carried out either neonatally, in the immunisation phase, or immediately before AIA elicitation, or during the chronic phase. In sympathectomised and non-sympathectomised AIA mice the inflammatory process (joint swelling, histopathology of inflammation and joint destruction), pain-related behaviour and cellular and humoral immune responses were analysed. Results Sympathectomy during AIA induction or neonatal sympathectomy significantly reduced the severity of acute AIA. Neither sympathectomy in the immunisation phase nor in the chronic phase influenced AIA. Flare-up reactions were reduced by sympathectomy just before flare-up or during the initial acute AIA stage. Sympathectomised AIA mice showed less hyperalgesia. Sympathectomy significantly reduced interleukin (IL) 2, IL-17 and transforming growth factor β in supernatants from lymph nodes and/or spleen cells and antigen-specific Th1-associated IgG2a in serum; IgG1 titres were unaffected. The ß blocker, propranolol, and the norepinephrine reuptake inhibitor bupropion produced similar anti-inflammatory effects, whereas the ß-adrenergic agonist isoproterenol increased AIA severity in neonatally sympathectomised mice. Conclusions Sympathetic activity mainly increases the severity of acute episodes of immune-mediated arthritis. Therapeutic reduction of sympathetic activity at acute stages attenuates inflammation, hyperalgesia and proinflammatory immune parameters.

[1]  H. Schaible,et al.  Molecular effects of interleukin-1β on dorsal root ganglion neurons: Prevention of ligand-induced internalization of the bradykinin 2 receptor and downregulation of G protein-coupled receptor kinase 2 , 2011, Molecular and Cellular Neuroscience.

[2]  H. Schaible,et al.  Tumor necrosis factor causes persistent sensitization of joint nociceptors to mechanical stimuli in rats. , 2010, Arthritis and rheumatism.

[3]  P. Tak,et al.  Role of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor α7 subunit gene knockout mice , 2010, Annals of the rheumatic diseases.

[4]  R. Straub,et al.  Catecholamine-producing cells in the synovial tissue during arthritis: modulation of sympathetic neurotransmitters as new therapeutic target , 2010, Annals of the rheumatic diseases.

[5]  H. Schaible,et al.  Spinal tumor necrosis factor alpha neutralization reduces peripheral inflammation and hyperalgesia and suppresses autonomic responses in experimental arthritis: a role for spinal tumor necrosis factor alpha during induction and maintenance of peripheral inflammation. , 2010, Arthritis and rheumatism.

[6]  R. Flavell,et al.  The sympathetic nervous system modulates CD4+FoxP3+ regulatory T cells via a TGF‐β‐dependent mechanism , 2009, Journal of leukocyte biology.

[7]  R. Straub,et al.  Neuronally released sympathetic neurotransmitters stimulate splenic interferon-gamma secretion from T cells in early type II collagen-induced arthritis. , 2008, Arthritis and rheumatism.

[8]  R. Straub,et al.  An early sympathetic nervous system influence exacerbates collagen-induced arthritis via CD4+CD25+ cells. , 2008, Arthritis and rheumatism.

[9]  H. Schaible,et al.  Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target. , 2008, Arthritis and rheumatism.

[10]  M. Gajda,et al.  Exacerbation of Antigen-Induced Arthritis in IFN-γ-Deficient Mice As a Result of Unrestricted IL-17 Response1 , 2007, The Journal of Immunology.

[11]  M. Schäfer,et al.  The Role of Noradrenergic Nerves in the Development of the Lymphoproliferative Disease in Fas-Deficient, lpr/lpr Mice1 , 2006, The Journal of Immunology.

[12]  E. Altschuler,et al.  A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. , 2006, International immunopharmacology.

[13]  L. Joosten,et al.  Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. , 2005, The American journal of pathology.

[14]  J. Schölmerich,et al.  An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis. , 2005, Arthritis and rheumatism.

[15]  D. Bellinger,et al.  The importance of timing of adrenergic drug delivery in relation to the induction and onset of adjuvant-induced arthritis , 2004, Brain, Behavior, and Immunity.

[16]  K. Książek,et al.  Interleukin-17: a mediator of inflammatory responses , 2004, Cellular and Molecular Life Sciences CMLS.

[17]  Kevin J. Tracey,et al.  The inflammatory reflex , 2002, Nature.

[18]  R. Straub,et al.  Involvement of the hypothalamic--pituitary--adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. , 2001, Arthritis and rheumatism.

[19]  A. Billiau,et al.  Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. , 1997, Journal of immunology.

[20]  H. Schaible,et al.  Afferent and spinal mechanisms of joint pain , 1993, Pain.

[21]  S. Felten,et al.  Acetylcholinesterase Staining and Choline Acetyltransferase Activity in the Young Adult Rat Spleen: Lack of Evidence for Cholinergic Innervation , 1993, Brain, Behavior, and Immunity.

[22]  K. Madden,et al.  Neonatal sympathetic denervation alters the development of in vitro spleen cell proliferation and differentiation , 1991, Brain, Behavior, and Immunity.

[23]  A. Basbaum,et al.  High-dose epinephrine acts at α2-adrenoceptors to suppress experimental arthritis , 1991, Brain Research.

[24]  J. Levine,et al.  Production of Hyperalgesic Prostaglandins by Sympathetic Postganglionic Neurons , 1989, Journal of neurochemistry.

[25]  K. Madden,et al.  Sympathetic neural modulation of the immune system I. Depression of T cell immunity in vivo and in vitro following chemical sympathectomy , 1989, Brain, Behavior, and Immunity.

[26]  A. Basbaum,et al.  Beta 2-adrenergic mechanisms in experimental arthritis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Dubner,et al.  A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia , 1987, Pain.

[28]  H. Schaible,et al.  Discharge characteristics of sympathetic efferents to the knee joint of the cat. , 1987, Journal of the autonomic nervous system.

[29]  A. Basbaum,et al.  Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[30]  W. B. van den Berg,et al.  Flare-up of antigen-induced arthritis in mice after challenge with intravenous antigen: studies on the characteristics of and mechanisms involved in the reaction. , 1984, Clinical and experimental immunology.

[31]  H. Schaible,et al.  Sensitization of unmyelinated sensory fibers of the joint nerve to mechanical stimuli by interleukin-6 in the rat: an inflammatory mechanism of joint pain. , 2007, Arthritis and rheumatism.

[32]  A. Basbaum,et al.  High-dose epinephrine acts at alpha 2-adrenoceptors to suppress experimental arthritis. , 1991, Brain research.